Back
Vertex Pharmaceuticals Stock Price Chart
Sponsored
VRTX
Sponsored
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Buy
58
VRTX
Vertex Pharmaceuticals
Last Price:
397.98
Seasonality Move:
11.79%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight selling pressure.
Vertex Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 397.26 | Buy |
20-day SMA: | 402.29 | Sell |
50-day SMA: | 412.15 | Sell |
200-day SMA: | 383.29 | Buy |
8-day EMA: | 399.01 | Sell |
20-day EMA: | 402.12 | Sell |
50-day EMA: | 407.64 | Sell |
200-day EMA: | 385.72 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.14 | Sell |
Relative Strength Index (14 RSI): | 41.98 | Sell |
Chaikin Money Flow: | -107087 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (396.36 - 413.98) | Sell |
Bollinger Bands (100): | (390.37 - 431.87) | Sell |
Vertex Pharmaceuticals Technical Analysis
Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 397.70 while VRTX 8-day simple moving average is 397.26, which is a Buy signal.
- The stock price of VRTX is 397.70 while Vertex Pharmaceuticals 20-day SMA is 402.29, which makes it a Sell.
- Vertex Pharmaceuticals 50-day simple moving average is 412.15 while VRTX share price is 397.70, making it a Sell technically.
- VRTX stock price is 397.70 and Vertex Pharmaceuticals 200-day simple moving average is 383.29, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Buy
58
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $397.70. The Score for VRTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
102.73B
Price in USD:
397.70
Share Volume:
787.23K
Vertex Pharmaceuticals 52-Week Range
52-Week High:
448.40
52-Week Low:
316.43
Buy
58
Vertex Pharmaceuticals (VRTX)
is a Buy
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 397.70 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is not overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 397.70 while VRTX 8-day exponential moving average is 399.01, which is a Sell signal.
- The stock price of VRTX is 397.70 while Vertex Pharmaceuticals 20-day EMA is 402.12, which makes it a Sell.
- Vertex Pharmaceuticals 50-day exponential moving average is 407.64 while VRTX share price is 397.70, making it a Sell technically.
- VRTX stock price is 397.70 and Vertex Pharmaceuticals 200-day simple moving average is 385.72, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.29 per share, an increase this year of $1.64 per share, and an increase next year of $1.39 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is -4.14, suggesting Vertex Pharmaceuticals is a Sell
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 41.98, which suggest Vertex Pharmaceuticals is oversold
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (396.36 - 413.98), which suggest Vertex Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (390.37 - 431.87), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.